S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Clovis Oncology Announces First Patient Enrolled in Lucitanib Phase 2 Study in FGF-aberrant Advanced Breast Cancer|
|Clovis Oncology to Offer $200 Million of Convertible Senior Notes|
|Clovis Oncology Announces Exercise in Full by Initial Purchasers of Their Option to Purchase an Additional $37.5 Million Aggregate Principal Amount of the Company’s 2.50% Convertible Senior Notes Due 2021|
|Clovis Oncology Announces Second Quarter 2014 Operating Results|
|Data from Ongoing Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Safety and Clinical Activity, Validate Differentiated Strategy|
|Clovis Oncology to Announce Second Quarter 2014 Financial Results and Host Webcast Conference Call on August 7|
|Clovis Oncology to Present at the 2014 Morgan Stanley Global Healthcare Conference|
Click above to view more mutual fund data and stats for clvs - Clovis Oncology Inc.